| Assessment of the global trigger tool to measure, monitor and evaluate patient safety in cancer patients: reliability concerns are raised TO Mattsson, JL Knudsen, J Lauritsen, K Brixen, J Herrstedt BMJ quality & safety 22 (7), 571-579, 2013 | 73 | 2013 |
| Non-intercepted dose errors in prescribing anti-neoplastic treatment: a prospective, comparative cohort study TO Mattsson, B Holm, H Michelsen, JL Knudsen, K Brixen, J Herrstedt Annals of Oncology 26 (5), 981-986, 2015 | 41 | 2015 |
| Improving electronic oral chemotherapy prescription: can we build a safer system? SN Weingart, T Mattsson, J Zhu, LN Shulman, M Hassett Journal of oncology practice 8 (6), e168-e173, 2012 | 34 | 2012 |
| Does adding an appended oncology module to the Global Trigger Tool increase its value? TO Mattsson, JL Knudsen, K Brixen, J Herrstedt International Journal for Quality in Health Care 26 (5), 553-560, 2014 | 26 | 2014 |
| Patient self‐testing of white blood cell count and differentiation: A study of feasibility and measurement performance in a population of Danish cancer patients T Otto Mattsson, CL Lindhart, J Schöley, L Friis‐Hansen, J Herrstedt European Journal of Cancer Care 29 (1), e13189, 2020 | 18 | 2020 |
| Validity of antineoplastic procedure codes in the Danish national patient registry: the case of colorectal cancer MO Broe, PB Jensen, TO Mattsson, A Pottegård Epidemiology 31 (4), 599-603, 2020 | 16 | 2020 |
| Patient involvement in evaluation of safety in oral antineoplastic treatment: a failure mode and effects analysis in patients and health care professionals TO Mattsson, H Lipczak, A Pottegård Quality Management in Healthcare 28 (1), 33-38, 2019 | 9 | 2019 |
| End-of-life anticancer treatment–a nationwide registry-based study of trends in the use of chemo-, endocrine, immune-, and targeted therapies TO Mattsson, A Pottegård, TL Jørgensen, A Green, M Bliddal Acta oncologica 60 (8), 961-967, 2021 | 8 | 2021 |
| Point-of-care used in the treatment of older patients with cancer. The perception and experience of nurses CL Lindhardt, TO Mattsson, JJ Mebrouk Applied Nursing Research 53, 151268, 2020 | 4 | 2020 |
| Employment status among cancer survivors in a Late Effects Clinic in Denmark AS Skovgaards, TO Mattsson, LK Tolstrup Journal of Cancer Survivorship, 1-9, 2023 | | 2023 |
| 2131P Real-life experiences from a late effects clinic: An investigation of health-related quality of life in Danish cancer survivors LK Tolstrup, KB Dieperink, LH Clausen, L Fechner, T Mattsson Annals of Oncology 34, S1112, 2023 | | 2023 |
| End-of-life anticancer treatment. A Nationwide registry-based study TO Mattsson, A Pottegård, TL Jørgensen, A Green, M Bliddal ISPE All Access: 35 years of real-world evidence, 2020 | | 2020 |
| Validity of chemotherapy procedure codes in the Danish National Patient Registry: A validation study MO Broe, TO Mattsson, A Pottegard Pharmacoepidemiology and Drug Safety 28 (2, SI), 160, 2019 | | 2019 |
| Home monitoring of blood-test by elderly cancer patients CL Lindhardt, TO Mattsson, J Herrstedt, L Friis-Hansen | | 2019 |
| PhD Oral Defence Session TO Mattsson Department of Clinical Research, University of Southern Denmark, 2015 | | 2015 |
| Evaluation of Patient Safety in Clinical Oncology: Ph. D. Thesis TO Mattsson Faculty of Health Sciences, University of Southern Denmark, 2015 | | 2015 |
| Prevalence of prescribing errors resulting in administration of incorrect dosages of antineoplastic treatment. TO Mattsson, B Holm, HM Michelsen, JL Knudsen, K Brixen, J Herrstedt Journal of Clinical Oncology 32 (15_suppl), 6614-6614, 2014 | | 2014 |
| Measuring adverse event rates in oncology inpatients using trigger tools: An assessment of measurement properties. TO Mattsson, K Brixen, JL Knudsen, J Herrstedt Journal of Clinical Oncology 30 (34_suppl), 235-235, 2012 | | 2012 |
| Measuring adverse events in oncology inpatients using Global Trigger Tools; Sense or nonsense? TO Mattsson, K Brixen, JL Knudsen, J Herrstedt | | 2012 |
